Article

Big discrepancies seen between guidelines, glaucoma care

In medicine, as in many other professions, a gap exists between ideal or recommended behavior and what happens in the complex, messy "real world," where an infinite number of factors cause deviations from the desired goal. This is certainly true in glaucoma treatment, where various studies in recent years have shown that physicians fail to provide or document services such as optic nerve head photography as often as preferred practice guidelines recommend.

In medicine, as in many other professions, a gap exists between ideal or recommended behavior and what happens in the complex, messy "real world," where an infinite number of factors cause deviations from the desired goal. This is certainly true in glaucoma treatment, where various studies in recent years have shown that physicians fail to provide or document services such as optic nerve head photography as often as preferred practice guidelines recommend.

"They may or may not be appropriate for every single patient," he noted.

Also, there is the issue of updating the guidelines to remain in sync with prevailing attitudes and the latest research. According to the AAO Web site, PPPs are valid for 5 years from the time of publication, although they may be updated with revisions as needed. The Preferred Practice Patterns Committee Glaucoma Panel approved the primary open-angle glaucoma (POAG) guidelines in November 2003 with a limited revision. The limited revision pertained to central corneal thickness measurements as part of an initial evaluation, help with determining target IOP, and recommendations for repeating this measurement.

"The guidelines are evolving, and there are different guidelines for different purposes," said Louis B. Cantor, MD, director of the glaucoma service at Indiana University School of Medicine, Indianapolis. "Also, how we think about glaucoma and stage glaucoma is changing."

Most guidelines describe ocular hypertension or mild, moderate, or severe glaucoma and recommend that physicians follow certain steps associated with each stage.

"Those are typically based on staging the disease by the visual field," Dr. Cantor said.

"However, a lot of the nerve can be damaged before anything shows up in the visual field. So now as we start to think about glaucoma as an optic neuropathy and staging the disease via the optic nerve instead of the visual field, we run into problems with some of the older guidelines because we're not talking the same language. That's part of the reason why there's confusion out there," said Dr. Cantor, who is the Jay C. and Lucile L. Kahn Professor of Glaucoma Research and Education at Indiana's ophthalmology department.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.